News

News
rennes business
Interview with Allan Rodrigues - CEO of VitaDX by Destination Rennes Business
25 avril 2022 -

Allan Rodriguez - CEO of VitaDX was interviewed by Destination Rennes to present the startup VitaDX and its in vitro diagnostic medical device…

ouest france
An article from Ouest France: A breton artificial intelligence to detect bladder cancer
30 novembre 2021 -

Thanks to Ouest France for this very nice article.
VitaDX has been partnering for several years with LTSI  (Signal and Image Processing…

ECOSYSTEME
ECOSYSTEME - Interview of Allan Rodriguez and Dr Camélia Radulescu on B SMART
20 septembre 2021 -

Thomas Hugues welcomes Allan Rodriguez (VitaDX) and Camélia Radulescu (Foch hospital) to ÉCOSYSTÈME to talk about VitaDX's new diagnostic solution…

VitaDX
4th round of financing for VitaDX
21 septembre 2020 -

VitaDX completes a €3M financing round with its historical investors GO CAPITAL, ODYSSEE Venture and FFBB Management and its financial partners…

VisioCyt
CE marking of the VisioCyt® solution
11 février 2020 -

VitaDX is very proud to announce the CE marking of its first software solution dedicated to bladder cancer diagnosis: VisioCyt®.

VitaDX, Go Capital, Odyssee Venture et Auriga
VitaDX raises €4 million from GO CAPITAL, AURIGA Partners, ODYSSEE Venture and FFBB Management
9 juillet 2019 -

This fundraising will allow VitaDX to finalize the development and ensure the commercial deployment of its first early bladder cancer detection…

La Tribune
”Paroles d’Experts” show by La Tribune
16 juillet 2018 -

Allan Rodriguez (CEO and co-founder of VitaDX) and Pascal Eschwège (Professor of Urology at the University Hospital of Nancy and co-founder of…

DeepTech4Good Paris
DeepTech4Good Paris
12 juillet 2018 -

VitaDX is very happy to be a Health & Wellness Laureate at DeepTech4Good !

Realize
REALIZE AstraZeneca
11 juillet 2018 -

VitaDX is very pleased to be part of the 5 Therapeutic Innovation Startups selected by AstraZeneca to be part of the support program REALIZE!